AAPL325.28+9.94 (+3.15%) ▲|ABBV253.57+2.66 (+1.06%) ▲|ABT103.46-1.77 (-1.68%) ▼|ACN177.87+2.07 (+1.18%) ▲|ADBE249.01-5.85 (-2.30%) ▼|AMAT456.75-12.10 (-2.58%) ▼|AMD505.31-15.79 (-3.03%) ▼|AMGN382.46-8.82 (-2.25%) ▼|AMT172.51-2.92 (-1.66%) ▼|AMZN251.64-0.76 (-0.30%) ▼|AVGO361.91-2.47 (-0.68%) ▼|AXP320.62-1.18 (-0.37%) ▼|BA204.88-1.55 (-0.75%) ▼|BAC62.50-0.18 (-0.28%) ▼|BKNG174.23+0.80 (+0.46%) ▲|BLK1,062.91-9.12 (-0.85%) ▼|BMY63.92-0.50 (-0.77%) ▼|BNY162.53+0.02 (+0.01%) ▲|BRK-B506.43-0.29 (-0.06%) ▼|C138.20+0.40 (+0.29%) ▲|CAT803.92-11.64 (-1.43%) ▼|CL87.93-0.10 (-0.11%) ▼|CMCSA25.19+0.60 (+2.44%) ▲|COF207.00-3.86 (-1.83%) ▼|COP137.45+0.92 (+0.67%) ▲|COST901.51-1.09 (-0.12%) ▼|CRM242.83-1.33 (-0.54%) ▼|CSCO107.85-1.58 (-1.44%) ▼|CVS95.44+0.06 (+0.06%) ▲|CVX213.10-0.72 (-0.33%) ▼|DE677.02-0.20 (-0.03%) ▼|DHR201.03-3.83 (-1.87%) ▼|DIS105.12+0.94 (+0.90%) ▲|DUK119.59-0.85 (-0.70%) ▼|EMR147.71-2.63 (-1.75%) ▼|FDX311.71+2.52 (+0.82%) ▲|GD354.24+1.57 (+0.45%) ▲|GE323.54-1.88 (-0.58%) ▼|GEV923.32-27.72 (-2.91%) ▼|GILD144.92-0.73 (-0.50%) ▼|GM85.87+2.11 (+2.52%) ▲|GOOG330.30+1.92 (+0.58%) ▲|GOOGL332.68+2.03 (+0.61%) ▲|GS1,017.64-11.14 (-1.08%) ▼|HD305.04-5.41 (-1.74%) ▼|HON201.98-2.95 (-1.44%) ▼|IBM233.73-6.21 (-2.59%) ▼|INTC101.00-5.24 (-4.93%) ▼|INTU311.98-1.96 (-0.63%) ▼|ISRG360.87+7.63 (+2.16%) ▲|JNJ266.59-0.49 (-0.18%) ▼|JPM353.02-1.69 (-0.48%) ▼|KO88.00+0.45 (+0.51%) ▲|LIN461.04-5.62 (-1.20%) ▼|LLY1,123.98-0.23 (-0.02%) ▼|LMT528.40+3.94 (+0.75%) ▲|LOW196.31-2.29 (-1.15%) ▼|LRCX299.98-15.86 (-5.02%) ▼|MA564.61-2.89 (-0.51%) ▼|MCD252.96-0.52 (-0.21%) ▼|MDLZ62.28-0.14 (-0.22%) ▼|MDT91.62-0.27 (-0.29%) ▼|META643.23-10.47 (-1.60%) ▼|MMM162.74-1.66 (-1.01%) ▼|MO68.57+0.68 (+1.00%) ▲|MRK144.69-2.85 (-1.93%) ▼|MS213.33-2.02 (-0.94%) ▼|MSFT490.76-0.90 (-0.18%) ▼|MU981.93-45.84 (-4.46%) ▼|NEE82.68+0.03 (+0.04%) ▲|NFLX75.86-0.17 (-0.22%) ▼|NKE36.59-0.76 (-2.03%) ▼|NOW131.14+0.03 (+0.02%) ▲|NVDA218.38-5.29 (-2.37%) ▼|ORCL153.94-7.69 (-4.76%) ▼|PEP136.87+0.18 (+0.13%) ▲|PFE27.53-0.26 (-0.92%) ▼|PG143.06+0.42 (+0.30%) ▲|PLTR165.70-3.83 (-2.26%) ▼|PM189.55+3.84 (+2.07%) ▲|QCOM177.81+1.41 (+0.80%) ▲|RTX197.47-0.08 (-0.04%) ▼|SBUX99.40-0.65 (-0.64%) ▼|SCHW107.06+0.52 (+0.48%) ▲|SO88.07-0.28 (-0.31%) ▼|SPG205.23+0.70 (+0.34%) ▲|T25.62+0.47 (+1.87%) ▲|TMO602.65-3.05 (-0.50%) ▼|TMUS176.76-0.58 (-0.33%) ▼|TSLA363.84-3.98 (-1.08%) ▼|TXN258.73-2.86 (-1.09%) ▼|UBER72.38+1.30 (+1.83%) ▲|UNH389.44-3.62 (-0.92%) ▼|UNP285.24+0.50 (+0.18%) ▲|UPS99.84+0.62 (+0.62%) ▲|USB62.24+0.13 (+0.20%) ▲|V367.19-0.20 (-0.05%) ▼|VZ49.91+0.17 (+0.33%) ▲|WFC89.12-0.56 (-0.62%) ▼|WMT105.81-0.02 (-0.02%) ▼|XOM165.50+1.27 (+0.77%) ▲|AAPL325.28+9.94 (+3.15%) ▲|ABBV253.57+2.66 (+1.06%) ▲|ABT103.46-1.77 (-1.68%) ▼|ACN177.87+2.07 (+1.18%) ▲|ADBE249.01-5.85 (-2.30%) ▼|AMAT456.75-12.10 (-2.58%) ▼|AMD505.31-15.79 (-3.03%) ▼|AMGN382.46-8.82 (-2.25%) ▼|AMT172.51-2.92 (-1.66%) ▼|AMZN251.64-0.76 (-0.30%) ▼|AVGO361.91-2.47 (-0.68%) ▼|AXP320.62-1.18 (-0.37%) ▼|BA204.88-1.55 (-0.75%) ▼|BAC62.50-0.18 (-0.28%) ▼|BKNG174.23+0.80 (+0.46%) ▲|BLK1,062.91-9.12 (-0.85%) ▼|BMY63.92-0.50 (-0.77%) ▼|BNY162.53+0.02 (+0.01%) ▲|BRK-B506.43-0.29 (-0.06%) ▼|C138.20+0.40 (+0.29%) ▲|CAT803.92-11.64 (-1.43%) ▼|CL87.93-0.10 (-0.11%) ▼|CMCSA25.19+0.60 (+2.44%) ▲|COF207.00-3.86 (-1.83%) ▼|COP137.45+0.92 (+0.67%) ▲|COST901.51-1.09 (-0.12%) ▼|CRM242.83-1.33 (-0.54%) ▼|CSCO107.85-1.58 (-1.44%) ▼|CVS95.44+0.06 (+0.06%) ▲|CVX213.10-0.72 (-0.33%) ▼|DE677.02-0.20 (-0.03%) ▼|DHR201.03-3.83 (-1.87%) ▼|DIS105.12+0.94 (+0.90%) ▲|DUK119.59-0.85 (-0.70%) ▼|EMR147.71-2.63 (-1.75%) ▼|FDX311.71+2.52 (+0.82%) ▲|GD354.24+1.57 (+0.45%) ▲|GE323.54-1.88 (-0.58%) ▼|GEV923.32-27.72 (-2.91%) ▼|GILD144.92-0.73 (-0.50%) ▼|GM85.87+2.11 (+2.52%) ▲|GOOG330.30+1.92 (+0.58%) ▲|GOOGL332.68+2.03 (+0.61%) ▲|GS1,017.64-11.14 (-1.08%) ▼|HD305.04-5.41 (-1.74%) ▼|HON201.98-2.95 (-1.44%) ▼|IBM233.73-6.21 (-2.59%) ▼|INTC101.00-5.24 (-4.93%) ▼|INTU311.98-1.96 (-0.63%) ▼|ISRG360.87+7.63 (+2.16%) ▲|JNJ266.59-0.49 (-0.18%) ▼|JPM353.02-1.69 (-0.48%) ▼|KO88.00+0.45 (+0.51%) ▲|LIN461.04-5.62 (-1.20%) ▼|LLY1,123.98-0.23 (-0.02%) ▼|LMT528.40+3.94 (+0.75%) ▲|LOW196.31-2.29 (-1.15%) ▼|LRCX299.98-15.86 (-5.02%) ▼|MA564.61-2.89 (-0.51%) ▼|MCD252.96-0.52 (-0.21%) ▼|MDLZ62.28-0.14 (-0.22%) ▼|MDT91.62-0.27 (-0.29%) ▼|META643.23-10.47 (-1.60%) ▼|MMM162.74-1.66 (-1.01%) ▼|MO68.57+0.68 (+1.00%) ▲|MRK144.69-2.85 (-1.93%) ▼|MS213.33-2.02 (-0.94%) ▼|MSFT490.76-0.90 (-0.18%) ▼|MU981.93-45.84 (-4.46%) ▼|NEE82.68+0.03 (+0.04%) ▲|NFLX75.86-0.17 (-0.22%) ▼|NKE36.59-0.76 (-2.03%) ▼|NOW131.14+0.03 (+0.02%) ▲|NVDA218.38-5.29 (-2.37%) ▼|ORCL153.94-7.69 (-4.76%) ▼|PEP136.87+0.18 (+0.13%) ▲|PFE27.53-0.26 (-0.92%) ▼|PG143.06+0.42 (+0.30%) ▲|PLTR165.70-3.83 (-2.26%) ▼|PM189.55+3.84 (+2.07%) ▲|QCOM177.81+1.41 (+0.80%) ▲|RTX197.47-0.08 (-0.04%) ▼|SBUX99.40-0.65 (-0.64%) ▼|SCHW107.06+0.52 (+0.48%) ▲|SO88.07-0.28 (-0.31%) ▼|SPG205.23+0.70 (+0.34%) ▲|T25.62+0.47 (+1.87%) ▲|TMO602.65-3.05 (-0.50%) ▼|TMUS176.76-0.58 (-0.33%) ▼|TSLA363.84-3.98 (-1.08%) ▼|TXN258.73-2.86 (-1.09%) ▼|UBER72.38+1.30 (+1.83%) ▲|UNH389.44-3.62 (-0.92%) ▼|UNP285.24+0.50 (+0.18%) ▲|UPS99.84+0.62 (+0.62%) ▲|USB62.24+0.13 (+0.20%) ▲|V367.19-0.20 (-0.05%) ▼|VZ49.91+0.17 (+0.33%) ▲|WFC89.12-0.56 (-0.62%) ▼|WMT105.81-0.02 (-0.02%) ▼|XOM165.50+1.27 (+0.77%) ▲|

30.6 C

New York

Thursday, September 10, 2026

/C O R R E C T I O N — Partillion Bioscience/

Holdun Family Office (Bahamas) Limited Confirms the Conclusion of its Licensed Wealth Management Business

Drivvr AI Welcomes Automotive Marketing Veteran Brian Voss as National Sales Director

Tag: body

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.^3,⁴ A final decision on the approval in the European Union is expected in the coming months.

GirlStyle Unveils Inaugural “GirlStyle NextGen Glowing Awards 2025,” Illuminating the Future of Beauty

HONG KONG, June 20, 2025 /PRNewswire/ -- The beauty industry marks a significant milestone! GirlStyle, a leading female lifestyle information platform under PressLogic, proudly...

New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure

Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20, 2025 /CNW/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the...

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

SURGLASSES Launches the World’s First AI Anatomy Table

Asclepius AI Table sets a new benchmark for intelligent, hands-on medical learning. TAIPEI, June 19, 2025 /PRNewswire/ -- Surglasses Inc. today announced the launch of...

Online Casinos Canada 2025: RoboCat Inaugurates New Online Slots and Instant Games

As Part of the Brand’s Ongoing Efforts for Remaining a Best Choice Amongst All The Online Casinos Canada, RoboCat Has Renovated Their Online Slots and Instant Games Sections with New Titles and Exclusive Bonuses

As Part of the Brand’s Ongoing Efforts for Remaining a Best Choice Amongst All The Online Casinos Canada, RoboCat Has Renovated Their Online Slots and Instant Games Sections with New Titles and Exclusive Bonuses

Intrinsic Therapeutics, Inc. Announces That ISASS Has Issued Updated 2025 Recommendations and Coverage Criteria for Barricaid Bone-Anchored Annular Closure

BOSTON, June 19, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company committed to redefining the standard of care for lumbar discectomy patients with...

Johnson//Becker Files Lawsuit in California Federal Court for Igloo Cooler Injuries

ST. PAUL, Minn., June 19, 2025 /PRNewswire/ -- Johnson//Becker, PLLC, is a national product liability law firm with a strong track record of representing...

Momcozy Pop-Up Unveils the Best Nursing Bra for Summer Comfort: the Momcozy CoolFit Nursing Bra

Beverly Hills, CA, June 19, 2025 (GLOBE NEWSWIRE) -- From June 1 to 15, Momcozy, the trusted brand in maternity products and breastfeeding essentials, has hosted an exclusive pop-up experience at the Babylist Showroom in Beverly Hills, inviting local moms to engage with its latest innovation—the Momcozy CoolFit Nursing Bra. The hands-on event, held under the official theme “Try & Tell: Mom’s Summer Discovery,” gave mothers the opportunity to experience the product firsthand, offer candid feedback, and enjoy thoughtfully curated rewards in return.

Happy Ring Earns Second FDA Clearance–Now Approved for At-Home Sleep Testing to Simplify the Diagnosis and Treatment of Sleep Apnea and Related Health Conditions

First FDA-cleared smart ring for multi-night sleep testing and 24/7 biometrics — to catch disease early—years before standard care. AUSTIN, Texas, June 19, 2025 /PRNewswire/...

Aspen Laser and TheraLight Announce Key Executive Appointments to Support Growth and Innovation

LINDON, Utah, June 19, 2025 /PRNewswire/ -- Aspen Laser Systems, LLC and TheraLight, LLC, pioneers in photobiomodulation and integrative wellness technologies, are pleased to...

Divine Mercy University Press Release Mini-Version of the CCMMP

The Mini-Version of the Meta-Model is intended for those who want a short, readable summary of the Meta-Model. STERLING, Va., June 19, 2025 /PRNewswire/ -- Divine...

TOMY to Hold “TOMICA Expo 2025 in TAIWAN” to Experience World of TOMICA from June 28 (Sat) to September 14 (Sun), 2025 in Taiwan...

- TOMICA Expo Commemorative Model "Taiwan Taxi" to be Sold - TOKYO, June 19, 2025 /PRNewswire/ -- TOMY Company, Ltd., based in Katsushika Ward, Tokyo,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsBody